help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arif, S.
Right arrow Articles by Peakman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arif, S.
Right arrow Articles by Peakman, M.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 4439-4445, Copyright © 1996 by Endocrine Society


ARTICLES

Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease

S Arif, S Vallian, F Farzaneh, MM Zanone, SL James, M Pietropaolo, S Hettiarachchi, D Vergani, GS Conway and M Peakman
Department of Immunology, King's College School of Medicine, London, United Kingdom.

Autoantibodies directed against steroid hormone-producing cells (SCA) detectable by immunofluorescence are typically found in a small proportion of patients with premature ovarian failure (POF) as well as in other endocrine autoimmune diseases. The SCA pattern stains cells in the outer zones of the adrenal cortex, ovary, and testis. To identify the molecular target of SCA, an adrenal complementary DNA expression library was screened using SCA-positive serum, and the steroid enzyme 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) was identified. Only 1 of 48 (2%) patients with idiopathic POF, not pre-selected for the presence of other autoimmune diseases, had SCA by immunofluorescence, whereas 10 of 48 (21%) had anti-3 beta HSD autoantibodies detectable by immunoblot using recombinant human enzyme compared with 6 of 115 (5%) control subjects (P = 0.002). Absorption of SCA-positive serum with recombinant human 3 beta HSD abolished the immunofluorescence pattern. We also examined the prevalence of anti-3 beta HSD autoantibodies in other endocrine autoimmune diseases. Two of 112 (2%) diabetic patients, but none of the thyroid or Addisonian patients, had SCA by immunofluorescence. Twenty-six (23%) diabetic subjects (P < 0.001 vs. controls), 3 of 18 thyroid patients (P > 0.05 vs. controls), and none of 4 Addisonian patients had anti-3 beta HSD autoantibodies. 3 beta HSD is the first steroid cell autoantigen defined at the molecular level to be associated with idiopathic POF occurring in the absence of other polyglandular diseases. Autoantibodies to 3 beta HSD in patients with other organ-specific autoimmune diseases indicate that the enzyme behaves as a typical target of polyendocrine autoimmunity. Anti-3 beta HSD autoantibodies in patients with POF may provide a marker of those subjects whose ovarian failure is autoimmune in origin and, as recent studies suggest, may be salvageable with glucocorticoid treatment.


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
D. Goswami and G. S. Conway
Premature ovarian failure
Hum. Reprod. Update, July 1, 2005; 11(4): 391 - 410.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
T. Forges, P. Monnier-Barbarino, G.C. Faure, and M.C. Bene
Autoimmunity and antigenic targets in ovarian pathology
Hum. Reprod. Update, March 1, 2004; 10(2): 163 - 175.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta
Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction
Endocr. Rev., June 1, 2002; 23(3): 327 - 364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Bagavant, C. Sharp, B. Kurth, and K. S. K. Tung
Induction and Immunohistology of Autoimmune Ovarian Disease in Cynomolgus Macaques (Macaca fascicularis)
Am. J. Pathol., January 1, 2002; 160(1): 141 - 149.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Arif, R. Varela-Calvino, G. S. Conway, and M. Peakman
3{beta} Hydroxysteroid Dehydrogenase Autoantibodies in Patients with Idiopathic Premature Ovarian Failure Target N- and C-Terminal Epitopes
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5892 - 5897.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Reimand, P. Peterson, H. Hyöty, R. Uibo, I. Cooke, A. P. Weetman, and K. J. E. Krohn
3{beta}-Hydroxysteroid Dehydrogenase Autoantibodies Are Rare in Premature Ovarian Failure
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2324 - 2326.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. H. Melner and F. A. Feltus
Editorial: AutoImmune Premature Ovarian Failure--Endocrine Aspects of a T Cell Disease
Endocrinology, August 1, 1999; 140(8): 3401 - 3403.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Arif, J. A. Underhill, P. Donaldson, G. S. Conway, and M. Peakman
Human Leukocyte Antigen-DQB1* Genotypes Encoding Aspartate at Position 57 Are Associated with 3{beta}-Hydroxysteroid Dehydrogenase Autoimmunity in Premature Ovarian Failure
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1056 - 1060.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society